Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Zacks Research
Zacks Research upgraded shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a strong sell rating to a hold rating in a research note published on Tuesday,Zacks.com reports. Other equities analysts have also recently issued reports about the company. Wall Street Zen cut Bio-Rad Laboratories from a “buy” rating to a “hold” rating in a […]
More Stories
Trump Threatens to Target Iran’s Bridges, Power Plants on April 7 if Strait of Hormuz Not Reopened
By Jacki Thrapp U.S. President Donald Trump has threatened to target Iran’s power plants and bridges on April 7 if...
Iran Says It Will Retaliate If Civilian Infrastructure Is Targeted Amid Trump Deadline
By Jack Phillips Iranian officials on Sunday said the country would carry out more forceful attacks on targets if the...
Artemis II Day 4: Manual Flight in Deep Space, Lunar Flyby Preparations, Easter Message
By T.J. Muscaro HOUSTON—NASA astronaut Christina Koch and Canadian Space Agency astronaut Jeremy Hansen have become the first people in...
Mega Mergers Return to Food Industry in 1st Quarter Amid Pressure for Lower Prices
By Panos Mourdoukoutas The first quarter of 2026 marked a renewed wave of megamergers in the food industry, as companies...
California-Based Family Members of Qasem Soleimani Arrested, Green Cards Revoked
By Jacki Thrapp Two family members of assassinated Islamic Revolutionary Guard Corps Major General Qasem Soleimani were arrested by federal...
‘WE GOT HIM!’: Trump Says US Forces Rescue 2nd Airman Downed in Iran
By Ryan Morgan U.S. forces have successfully rescued a second U.S. airman whose F-15 Strike Eagle fighter jet was shot...